Turbostart leads $1 mn investment in AI Health Highway

Turbostart, a global sector-agnostic venture capital platform, has made a $1 million investment in Ai Health Highway as part of its Pre-Series A round funding. Ai Health Highway focuses on providing tech-enabled screening tools that help in the early detection of non-communicable diseases (NCDs) and improving healthcare accessibility through India’s first Ai-enabled stethoscope, AiSteth. 

This investment is part of a larger $1.5 million funding, including co-investment from notable investors Rainmatter by Zerodha, The Chennai Angels, BITS BioCyTiH Foundation along with other angel investors. This crucial funding aims to empower Ai Health Highway to solidify its presence in India, accelerate regulatory approvals internationally, and broaden its AI/ML offerings in the Cardio-Respiratory domain.

AiSteth, India’s first AI-enabled stethoscope, is assisting healthcare professionals and non-specialists in interpreting heart sounds to support accurate clinical decisions. Utilising advanced AI and signal processing, AiSteth transforms traditional stethoscopes into screening tools capable of detecting cardiac disorders at an early stage.

The AI-enabled stethoscope integrates into existing workflows, equipping primary care providers with high-quality heart sound capture, analysis, and data-sharing capabilities, thereby enhancing the accessibility and affordability of healthcare solutions.

Founded in 2018, Ai Health Highway is on a mission to reduce global premature deaths due to NCDs by 30 per cent by 2030. NCDs account for over 41 million deaths annually, highlighting the need for early detection and intervention.